Context Therapeutics to Participate in Two January 2022 Investor Conferences

Context Therapeutics

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in January 2022.

Details of the events are as follows:

  • Biotech Showcase™ 2022: The company’s presentation will be available for on-demand viewing during the conference which will take place January 10-12, 2022. Additionally, Mr. Lehr will participate on the “Women’s Health: Progress and Innovation Continue to Drive Increased Investor Interest” panel taking place on January 12, 2022, at 8:00 a.m. PST. Details about the event can be found here: https://informaconnect.com/biotech-showcase/agenda/4/
  • Edison Group Open House: Global Healthcare 2022: The company’s presentation will be available for on-demand viewing during the conference which will take place January 25-27, 2022. Context will also participate in one-on-one meetings during the conference. To register for meetings with the Context team, please visit this link. Additionally, a replay of the company’s video presentation will be available on the Events page of the Investor Relations section of Context’s website, www.contexttherapeutics.com, for approximately 30 days after the meeting.
READ:  DeLisa Alexander Joins Qlik Board of Directors

Context Therapeutics Inc. is a women’s oncology company developing small molecule and immunotherapy treatments to transform care for breast and gynecological cancers.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.